COLY – One analyst on the CC tired to get COLY to take the bait on using a DNDN-like excuse that immunotherapy takes a long time to ramp up. To their credit, management didn’t bite.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.